Literature DB >> 16782178

MDMA use is associated with increased spatial BOLD fMRI visual cortex activation in human MDMA users.

R L Cowan1, E Haga, B deB Frederick, M S Dietrich, R L P Vimal, S E Lukas, P F Renshaw.   

Abstract

Previous animal studies have demonstrated that 3,4-methylenedioxymethamphetamine (MDMA) exposure causes serotonin axotomy that is greatest in occipital cortex (including primary visual cortex) where serotonergic axons innervate neurons and blood vessels. Human MDMA users have altered serotonergic function and reduced gray matter density in occipital cortex. The fMRI BOLD method is potentially sensitive to both the neuronal and vascular consequences of MDMA-induced serotonin toxicity. To test the hypothesis that MDMA users have altered visual system function, we used the fMRI BOLD technique to assay visual cortical activation after photic stimulation in a group of adult MDMA users. Because MDMA users worldwide are polydrug users and therefore difficult to match to comparison groups in terms of polydrug exposure, we conducted a primary within-group analysis examining the correlation between lifetime episodes of MDMA exposure and measures of visual cortical activation. The within-group correlational analysis in the MDMA user group revealed that the degree of prior MDMA exposure was significantly positively correlated with the number of activated pixels for photic stimulation (r=0.582, p=0.007). A secondary between-group comparison of MDMA users with non-MDMA users found overall greater levels of polydrug exposure in the MDMA user cohort but no significant differences in visual cortical activation measures between the two groups. Additional research is needed to clarify the origin and significance of the current findings.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16782178     DOI: 10.1016/j.pbb.2006.04.024

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  11 in total

1.  Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.

Authors:  Christina R Di Iorio; Tristan J Watkins; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Baxter Rogers; Mohammed S Ansari; Ronald M Baldwin; Rui Li; Robert M Kessler; Ronald M Salomon; Margaret Benningfield; Ronald L Cowan
Journal:  Arch Gen Psychiatry       Date:  2011-12-05

2.  Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Authors:  John Karageorgiou; Mary S Dietrich; Evonne J Charboneau; Neil D Woodward; Jennifer U Blackford; Ronald M Salomon; Ronald L Cowan
Journal:  Neuroimage       Date:  2009-03-02       Impact factor: 6.556

3.  MDMA (Ecstasy) association with impaired fMRI BOLD thalamic coherence and functional connectivity.

Authors:  Ronald M Salomon; John Karageorgiou; Mary S Dietrich; Jessica Y McLellan; Evonne J Charboneau; Jennifer U Blackford; Ronald L Cowan
Journal:  Drug Alcohol Depend       Date:  2011-07-31       Impact factor: 4.492

4.  Human Ecstasy use is associated with increased cortical excitability: an fMRI study.

Authors:  Amy L Bauernfeind; Mary S Dietrich; Jennifer U Blackford; Evonne J Charboneau; James G Lillevig; Christopher J Cannistraci; Neil D Woodward; Aize Cao; Tristan Watkins; Christina R Di Iorio; Carissa Cascio; Ronald M Salomon; Ronald L Cowan
Journal:  Neuropsychopharmacology       Date:  2011-02-16       Impact factor: 7.853

5.  Occipital cortical proton MRS at 4 Tesla in human moderate MDMA polydrug users.

Authors:  Ronald L Cowan; Nicolas R Bolo; Mary Dietrich; Erica Haga; Scott E Lukas; Perry F Renshaw
Journal:  Psychiatry Res       Date:  2007-06-18       Impact factor: 3.222

6.  Neuroimaging in human MDMA (Ecstasy) users.

Authors:  Ronald L Cowan; Deanne M Roberts; James M Joers
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

7.  Human ecstasy (MDMA) polydrug users have altered brain activation during semantic processing.

Authors:  Tristan J Watkins; Vidya Raj; Junghee Lee; Mary S Dietrich; Aize Cao; Jennifer U Blackford; Ronald M Salomon; Sohee Park; Margaret M Benningfield; Christina R Di Iorio; Ronald L Cowan
Journal:  Psychopharmacology (Berl)       Date:  2012-12-16       Impact factor: 4.530

8.  Investigating the mechanisms of hallucinogen-induced visions using 3,4-methylenedioxyamphetamine (MDA): a randomized controlled trial in humans.

Authors:  Matthew J Baggott; Jennifer D Siegrist; Gantt P Galloway; Lynn C Robertson; Jeremy R Coyle; John E Mendelson
Journal:  PLoS One       Date:  2010-12-02       Impact factor: 3.240

9.  N-acetylaspartate (NAA) correlates inversely with cannabis use in a frontal language processing region of neocortex in MDMA (Ecstasy) polydrug users: a 3 T magnetic resonance spectroscopy study.

Authors:  Ronald L Cowan; James M Joers; Mary S Dietrich
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

10.  A long-term ecstasy-related change in visual perception.

Authors:  John Brown; Mark Edwards; Elinor McKone; Jeff Ward
Journal:  Psychopharmacology (Berl)       Date:  2007-04-25       Impact factor: 4.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.